DE69200412T2 - 3-substituierte 1,2,3,4-oxatriazol-5-iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel. - Google Patents

3-substituierte 1,2,3,4-oxatriazol-5-iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.

Info

Publication number
DE69200412T2
DE69200412T2 DE69200412T DE69200412T DE69200412T2 DE 69200412 T2 DE69200412 T2 DE 69200412T2 DE 69200412 T DE69200412 T DE 69200412T DE 69200412 T DE69200412 T DE 69200412T DE 69200412 T2 DE69200412 T2 DE 69200412T2
Authority
DE
Germany
Prior art keywords
pct
substituted
oxatriazol
imin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69200412T
Other languages
English (en)
Other versions
DE69200412D1 (de
Inventor
Gunnar Karup
Herbert Preikschat
Tim Corell
Bodil Lissau
Finn Clausen
Soeren Petersen
Boerge Alhede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AS
Original Assignee
GEA Farmaceutisk Fabrik AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEA Farmaceutisk Fabrik AS filed Critical GEA Farmaceutisk Fabrik AS
Publication of DE69200412D1 publication Critical patent/DE69200412D1/de
Application granted granted Critical
Publication of DE69200412T2 publication Critical patent/DE69200412T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69200412T 1991-02-12 1992-02-11 3-substituierte 1,2,3,4-oxatriazol-5-iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel. Expired - Fee Related DE69200412T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
PCT/DK1992/000043 WO1992013847A1 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
JP4071309A JPH05286950A (ja) 1991-02-12 1992-03-27 ３−置換１，２，３，４−オキサトリアゾール−５−イミン化合物およびその製造方法

Publications (2)

Publication Number Publication Date
DE69200412D1 DE69200412D1 (de) 1994-10-20
DE69200412T2 true DE69200412T2 (de) 1995-02-16

Family

ID=26063591

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69200412T Expired - Fee Related DE69200412T2 (de) 1991-02-12 1992-02-11 3-substituierte 1,2,3,4-oxatriazol-5-iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.

Country Status (23)

Country Link
US (1) US5405857A (de)
EP (1) EP0571485B1 (de)
JP (1) JPH05286950A (de)
AT (1) ATE111455T1 (de)
BG (1) BG97988A (de)
BR (1) BR9205624A (de)
CA (1) CA2100160A1 (de)
CZ (1) CZ163993A3 (de)
DE (1) DE69200412T2 (de)
DK (2) DK23891D0 (de)
ES (1) ES2062891T3 (de)
FI (1) FI933543A0 (de)
HU (1) HUT68643A (de)
IE (1) IE66384B1 (de)
LT (1) LT3184B (de)
LV (1) LV10617B (de)
NO (1) NO932822L (de)
PL (1) PL169685B1 (de)
PT (1) PT100121A (de)
RO (1) RO111190B1 (de)
SI (1) SI9210142A (de)
SK (1) SK78993A3 (de)
WO (1) WO1992013847A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
WO1996011191A1 (en) * 1994-10-07 1996-04-18 A/S Gea Farmaceutisk Fabrik Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis
US7867531B2 (en) 2005-04-04 2011-01-11 Curwood, Inc. Myoglobin blooming agent containing shrink films, packages and methods for packaging
US8470417B2 (en) 2004-04-02 2013-06-25 Curwood, Inc. Packaging inserts with myoglobin blooming agents, packages and methods for packaging
US8741402B2 (en) * 2004-04-02 2014-06-03 Curwood, Inc. Webs with synergists that promote or preserve the desirable color of meat
US8545950B2 (en) * 2004-04-02 2013-10-01 Curwood, Inc. Method for distributing a myoglobin-containing food product
US8029893B2 (en) 2004-04-02 2011-10-04 Curwood, Inc. Myoglobin blooming agent, films, packages and methods for packaging
US8110259B2 (en) 2004-04-02 2012-02-07 Curwood, Inc. Packaging articles, films and methods that promote or preserve the desirable color of meat
US8053047B2 (en) 2004-04-02 2011-11-08 Curwood, Inc. Packaging method that causes and maintains the preferred red color of fresh meat
US8653080B2 (en) * 2009-01-14 2014-02-18 Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015878B (en) * 1978-03-10 1982-05-26 Shell Int Research Biocidal compositions
US4239355A (en) 1979-02-05 1980-12-16 Vought Corporation Visual simulator projection system
US4329355A (en) * 1979-03-01 1982-05-11 Henry David W Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JP2708500B2 (ja) 1988-09-27 1998-02-04 三菱電機株式会社 積層形燃料電池
JP2905041B2 (ja) * 1993-07-02 1999-06-14 三菱電機株式会社 メッセージ送受信装置
JPH0720904A (ja) * 1993-07-05 1995-01-24 Toshiba Corp プロセス制御装置のリミッタ設定装置
JP2009102700A (ja) 2007-10-24 2009-05-14 Sumitomo Kinzoku Kozan Siporex Kk 軽量気泡コンクリート補強鉄筋用防錆剤

Also Published As

Publication number Publication date
JPH05286950A (ja) 1993-11-02
SK78993A3 (en) 1994-03-09
EP0571485B1 (de) 1994-09-14
RO111190B1 (ro) 1996-07-30
NO932822D0 (no) 1993-08-09
US5405857A (en) 1995-04-11
WO1992013847A1 (en) 1992-08-20
HUT68643A (en) 1995-07-28
HU9302323D0 (en) 1993-10-28
FI933543A (fi) 1993-08-11
LV10617B (en) 1995-12-20
BG97988A (bg) 1994-06-30
IE920436A1 (en) 1992-08-12
DE69200412D1 (de) 1994-10-20
CA2100160A1 (en) 1992-08-13
EP0571485A1 (de) 1993-12-01
FI933543A0 (fi) 1993-08-11
LTIP298A (en) 1994-08-25
CZ163993A3 (en) 1994-01-19
ES2062891T3 (es) 1994-12-16
BR9205624A (pt) 1994-11-08
PL169685B1 (pl) 1996-08-30
LV10617A (lv) 1995-04-20
ATE111455T1 (de) 1994-09-15
LT3184B (en) 1995-03-27
DK23891D0 (da) 1991-02-12
PT100121A (pt) 1993-05-31
DK0571485T3 (da) 1994-10-17
SI9210142A (en) 1995-08-31
IE66384B1 (en) 1995-12-27
NO932822L (no) 1993-08-09

Similar Documents

Publication Publication Date Title
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
ATE349425T1 (de) Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
NO20002788D0 (no) Nye forbindelser
ATE188469T1 (de) Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69200412T2 (de) 3-substituierte 1,2,3,4-oxatriazol-5-iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.
DE3575725D1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE3878111D1 (de) Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung.
ATE15897T1 (de) Ausgangsprodukte zur herstellung von cephalosporinen und verfahren zu ihrer herstellung.
ATE145903T1 (de) Kondensierte chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln zur behandlung von herz- kreislauferkrangen
ATE137237T1 (de) R-(-)-1-(5-hydroxyhexyl)-3-methyl-7- propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
DE59206772D1 (de) Neue 2-Amino-5-cyano-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EE9600109A (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69619868D1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
ATE69809T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten.
ATE182886T1 (de) Neue pyridin- bzw. pyridazinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ATE66468T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten.
DE68915750D1 (de) Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält.
ATA901889A (de) Verfahren zur herstellung von wasserlöslichem primycin und seinen komponenten sowie von diese enthaltenden pharmazeutischen präparaten
DE3991360T1 (de) Verfahren zur herstellung von wasserloeslichem primycin und seinen komponenten sowie von diese enthaltenden pharmazeutischen praeparaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee